Mutual Advisors LLC Sells 27 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Mutual Advisors LLC trimmed its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 1.5% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,749 shares of the medical equipment provider’s stock after selling 27 shares during the period. Mutual Advisors LLC’s holdings in Intuitive Surgical were worth $913,000 as of its most recent filing with the SEC.

Several other institutional investors have also made changes to their positions in the business. AQR Capital Management LLC grew its stake in shares of Intuitive Surgical by 12.6% in the 2nd quarter. AQR Capital Management LLC now owns 42,691 shares of the medical equipment provider’s stock valued at $18,958,000 after purchasing an additional 4,775 shares during the period. Susquehanna Fundamental Investments LLC bought a new stake in Intuitive Surgical in the second quarter valued at $29,776,000. Oliver Lagore Vanvalin Investment Group raised its stake in Intuitive Surgical by 11.2% during the second quarter. Oliver Lagore Vanvalin Investment Group now owns 4,431 shares of the medical equipment provider’s stock worth $1,971,000 after acquiring an additional 446 shares in the last quarter. MidWestOne Financial Group Inc. lifted its holdings in shares of Intuitive Surgical by 5.4% during the second quarter. MidWestOne Financial Group Inc. now owns 777 shares of the medical equipment provider’s stock valued at $346,000 after acquiring an additional 40 shares during the period. Finally, Rockport Wealth LLC boosted its stake in shares of Intuitive Surgical by 7.2% in the 2nd quarter. Rockport Wealth LLC now owns 61,472 shares of the medical equipment provider’s stock valued at $27,346,000 after purchasing an additional 4,104 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In other news, CFO Jamie Samath sold 270 shares of Intuitive Surgical stock in a transaction on Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares of the company’s stock, valued at $4,730,093.55. This trade represents a 2.99 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Gary S. Guthart sold 18,151 shares of the company’s stock in a transaction on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the sale, the chief executive officer now owns 24,219 shares of the company’s stock, valued at approximately $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 42,475 shares of company stock valued at $22,070,807 in the last ninety days. 0.90% of the stock is owned by insiders.

Analysts Set New Price Targets

ISRG has been the subject of a number of recent analyst reports. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research report on Friday. Oppenheimer reiterated a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. BTIG Research increased their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday, November 26th. Mizuho lifted their price objective on Intuitive Surgical from $440.00 to $500.00 in a research report on Thursday, October 17th. Finally, Royal Bank of Canada increased their target price on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Stock Down 4.0 %

Shares of Intuitive Surgical stock opened at $584.05 on Friday. Intuitive Surgical, Inc. has a 12 month low of $364.17 and a 12 month high of $616.00. The business has a fifty day simple moving average of $547.16 and a 200 day simple moving average of $504.35. The stock has a market cap of $208.03 billion, a PE ratio of 93.90, a price-to-earnings-growth ratio of 5.19 and a beta of 1.39.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.